We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · August 01, 2022

Tapinarof Cream for the Treatment of Plaque Psoriasis: 1-Year Safety and Efficacy

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
One-Year Safety and Efficacy of Tapinarof Cream for the Treatment of Plaque Psoriasis: Results from the PSOARING 3 Trial
J Am Acad Dermatol 2022 Jun 27;[EPub Ahead of Print], B Strober, L Stein Gold, R Bissonnette, AW Armstrong, L Kircik, SK Tyring, SC Piscitelli, PM Brown, DS Rubenstein, AM Tallman, MG Lebwohl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading